Charles River Laboratories International, Inc. is a leading provider of essential products and services that support the pharmaceutical and biotechnology industries. The company specializes in preclinical and clinical laboratory services, including drug discovery, safety assessment, and laboratory animal medicine. With a strong focus on advancing scientific research, Charles River operates globally, offering innovative solutions that enhance the development of new therapies and improve the quality of life. Its expertise spans various domains, including toxicology, genomics, and biopharmaceutical manufacturing.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

11 Patents

#30 in Wilmington, MA

#1,662 in Massachusetts

#27,563 in US

#51,873 in the World

Wilmington, MA, United States of America

Charles River Laboratories International, Inc.

Forward Citations = 3

12 inventors:

Kenneth S Henderson (5 out of 5 patents)

John Coiro (4 out of 11 patents)

Brian M Bilecki (4 out of 4 patents)

4. Thomas P Schupsky (4 out of 5 patents)

5. Olaf Stamm (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Charles River Laboratories International, Inc.. Retrieved from https://idiyas.com/company/charles-river-laboratories-international

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]